Brey RL. Stroke prevention in individuals with antiphospholipid antibodies. Lupus 1994;3:299C302. IgA aCL (P = 0.041). In seniors subjects IgG aCL were positive in 12 instances (12%), IgM aCL in 4 (4%), and IgA aCL in 37 (37%). Inside a comparison of these values to the people of adults, only seniors IgA aCL rate BAY-876 of recurrence was significantly higher (P = 0.0001) with the major contribution from the oldest subgroup. In order to avoid false positive results for IgG aCL in children and for IgA aCL in seniors, as well as false bad results for IgA aCL in children, we launched three new slice\off points: (1) 27.7 GPL for IgG aCL in children; (2) 13.8 APL for IgA aCL in children; and (3) 51.1 APL for IgA aCL in seniors subject matter. These data suggest that a correction for age of aCL slice\off levels should be considered to raise specificity and level of sensitivity for APS in pediatric as well as with seniors populations. J. Clin. Lab. Anal. 14:87C90, 2000. ? 2000 Wiley\Liss, Inc. Keywords: anticardiolipin antibodies, antiphospholipid antibodies, ELISA, pediatric anticardiolipin antibodies, adult anticardiolipin antibodies, seniors anticardiolipin antibodies Recommendations 1. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non\SLE disorders. Ann Intern Med 1990;112:682C698. [PubMed] [Google Scholar] 2. Asherson RA, Block S, Houssiau FA, Hughes GRV. Systemic lupus erythematosus and lymphoma: association with antiphospholipid syndrome. J Rheumatol 1991;18:277C279. [PubMed] [Google Scholar] 3. Stiehm ER, Fulginiti VA. Immunologic disorders in babies BAY-876 and children. Philadelphia, London, Toronto: WB Saunders Organization; 1980. 227 p. [Google Scholar] 4. Buckley CE, Buckley EG, Dorsey FC. Longitudinal changes in serum immunoglobulin levels in other humans. Fed Proc 1974;33:2036C2039. [PubMed] [Google Scholar] 5. Radl J, Sepers JM, Skvaril F, Morell A, Hijmans W. Immunoglobulins patterns of humans over 95 years of age. Clin Exp Immunol 1975; 22:84C90. [PMC free article] [PubMed] [Google Scholar] 6. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. Large prevalence of anti\cardiolipin and additional autoantibodies BMPR2 in a healthy seniors populace. Clin Exp Immunol 1987;69:557C565. [PMC free article] [PubMed] [Google Scholar] 7. Ruffatti A, Rossi L, Calligaro A, Del Ross T, Lagni M, Marson P, Todesco S. Autoantibodies of systemic rheumatic diseases in the healthy seniors. Gerontology 1990;36:104C111. [PubMed] [Google Scholar] 8. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984;28:47C55. [PubMed] [Google Scholar] 9. Solinger AM. Drug\related lupus. Clinical and etiologic considerations. Rheum Dis Clin North Am 1988;14:187C202. [PubMed] [Google Scholar] 10. Harris EN. Antiphospholipid antibodies (Annotation). Brit J Haematol 1990;74:1C9. [PubMed] [Google Scholar] 11. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;41(1):8C15. [PubMed] [Google Scholar] 12. Barrile A, Quattrocchi P, Bonanno D, et al. Presence and significance of anticardiolipin antibodies in infactious diseases. Recenti Prog Med 1992;83(6):350C353. [PubMed] [Google Scholar] 13. Kanariou M, Petridou E, Liatsis M, Revinthi K, Mandalenaki\Lambrou K, Trichopoulos D. Age patterns of immunoglobulins G, A and M in healthy children and the influence of breast feeding and vaccination status. Pediatr Allergy Immunol 1995;6(1):24C29. [PubMed] [Google Scholar] 14. Ruffatti A, Calligaro A, Del Ross T, et al. Anti\double\stranded DNA antibodies in the healthy seniors: prevalence and characteristics. J Clin Immunol 1900;10:300C303. [PubMed] [Google Scholar] 15. Derkesen RHWM. Clinical manifestation and management of the antiphospholipid syndrome. Lupus 1996;5:167C169. [PubMed] [Google Scholar] 16. Ruffatti A, De Silvestro G, Ghirardello A, et al. A Catastrophic antiphosphilid syndrome: the importance of high levels of warfarin anticoagulation. J Intern Med 1994;235:81C83. [PubMed] [Google Scholar] 17. Berstein ML, Salusinsky\Sternbach M, Bellefleur M, Esseltine DW. Thrombotic and hemorragic complications in children with the lupus BAY-876 anticoagulant. Am J Dis Child 1984;138:1132C1135. [PubMed] [Google Scholar] 18. Guariso G, Ruffatti A, Casonato A, Drigo P, Ghirardello A, Zancan L. Antiphospholipid syndrome in a child with trisomy 21: the relationship between anti\cardiolipin G antibodies and the von Willebrand element. Clin Exp Rheumatol 1992;10:613C616. [PubMed] [Google Scholar] 19. The Antiphospholipid Antibodies in Stroke Study Group . Clinical and laboratory findings.